KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only - Wikidata - awgldk - TriplyDB

KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only

KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only

http://www.wikidata.org/entity/Q34162787

about

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma The role of the ALK receptor in cancer biology Tackling ALK in non-small cell lung cancer: the role of novel inhibitors Non-small cell lung cancer: current treatment and future advances Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib Inhibitors of the anaplastic lymphoma kinase Differential methylation analysis for BS-seq data under general experimental design.CT-guided aspiration lung biopsy for EGFR and ALK gene mutation analysis of lung cancer.Rapid response of brain metastasis to crizotinib in a patient with KLC1-ALK fusion and MET gene amplification positive non-small cell lung cancer: a case report.Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR.Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.ALK in lung cancer: past, present, and future.A case of synchronous bilateral lung cancers: EML4-ALK positive adenocarcinoma in the right lung and adenocarcinoma in situ (the former bronchioloalveolar carcinoma) in the left lung.A rational diagnostic algorithm for the identification of ALK rearrangement in lung cancer: a comprehensive study of surgically treated Japanese patients.Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement.Molecular methods for somatic mutation testing in lung adenocarcinoma: EGFR and beyond Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer Clinicopathologic characteristics and therapeutic responses of Chinese patients with non-small cell lung cancer who harbor an anaplastic lymphoma kinase rearrangement.Genetic and biochemical alterations in non-small cell lung cancer.Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology Targeted resequencing reveals ALK fusions in non-small cell lung carcinomas detected by FISH, immunohistochemistry, and real-time RT-PCR: a comparison of four methods.Economic Analysis of Alternative Strategies for Detection of ALK Rearrangements in Non Small Cell Lung Cancer.Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategies ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy.Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.Sensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer.Tyrosine kinase gene rearrangements in epithelial malignancies.ALK: a tyrosine kinase target for cancer therapy.Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.Guideline Recommendations for Testing of ALK Gene Rearrangement in Lung Cancer: A Proposal of the Korean Cardiopulmonary Pathology Study Group.ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.

P2860

Q21129306-2A6EC244-DE56-486E-A48F-AF67CE01C3C3 Q26738384-719519F5-463C-485B-9C68-7107E5B35CCC Q26740329-4595D8EB-91D2-400A-BE69-B97E5B61983D Q26740333-B14D11E1-A130-42D5-A410-0961FAF4651E Q26741814-FFE895E2-FFBF-42C5-9AB0-E2BA31B3C3C4 Q26795555-4FAFDA1F-ED19-45F6-A3A8-CD2C7849B29C Q26828860-32B60B4E-5844-43C8-BD11-7056A5C7F168 Q27852699-11E71394-424D-48F0-A50A-68143E731B82 Q27853072-541264A9-9DC9-4F4F-8644-BA851074EE11 Q28267124-0B7C1FFF-4A45-40DD-A360-15711D8F180E Q31040608-36912B38-65E5-48B3-B648-92A3257D4F8E Q33684384-868C2A81-8030-4F0C-8AB4-867354137C0A Q33728943-70CAC148-F880-4C6E-958B-A45A7CF9875F Q33844713-372521B9-89BB-498C-B215-14E884E1F2DD Q34159011-2A535B09-C673-466D-833D-252CA671E770 Q34389047-3A7998C0-0787-4035-A9C9-D100EF6EE4BD Q34402260-877A60E9-31C4-4C4A-97B0-8452C17D1B1D Q34686818-DA41E1B7-4EDC-40E8-A32A-8B523232BA13 Q34924658-4C21CF18-10DA-493A-9572-7BD7071057C8 Q34947842-0ACE1CBE-75D3-4314-9197-E2D1F5BE5B2A Q35256603-90922F8A-3B2C-48B2-BF61-45DECD0E0B63 Q35256622-F5432771-9674-4443-90D7-8019781CCDD5 Q35805617-5B82C351-75C4-4F19-A1C8-8A56612A919A Q36096398-5E962B2F-F639-48B6-8A50-F2D22BAEA830 Q36121158-1851A13E-AFC0-4831-A662-5A8510284BFE Q36184584-7896F1D0-7AA4-4A4A-A030-835F1B63A542 Q36260477-D5BBDADA-0E50-48CD-83E3-070DAC2480F7 Q36384499-C1DFD9A8-1625-42BA-B194-AD2319F58149 Q36405628-1E4552F4-8348-4288-A9F6-05408C125591 Q36635602-2DA33D50-6B28-4782-9E3E-7C20402003AB Q36731901-F62D98DB-C3A1-4C46-9828-66FE5C819A50 Q36850900-F12CBC76-B2DD-4562-A62A-76268817E704 Q36866859-2BB66BCD-7DBA-46D5-8A3C-F6511693AD8E Q36946796-C4150F55-D671-47FD-8EF5-20CD9CED0367 Q37392933-F876EF71-11D7-4210-8781-00023437EA35 Q37515966-0DFA0484-1262-4B9E-A79A-5DD0B2746774 Q37518624-2CC9F572-1F9A-43F7-8FB7-6CB3006A0B17 Q37604076-84D8142A-1754-428D-8429-81CFD25C5351 Q37631021-EA54D833-2457-462D-97CC-CFF9768A9FEA Q37696243-86368E2F-5324-4318-AD22-1901F4D78FD5

P2860

KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only

http://www.wikidata.org/entity/Q34162787

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@ast

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@en

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@nl

type

label

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@ast

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@en

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@nl

prefLabel

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@ast

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@en

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@nl

P1433

Q34162787-DAE64EBF-6108-4806-8843-C0C6B55F510A

P1476

Q34162787-2BE1FAC1-7C06-489B-AF89-2E119FBBDA3B

P2093

Q34162787-13C5E270-AE6E-412D-9805-432B6F807264

Q34162787-316A5200-D969-47AE-BCB2-92693B3CC660

Q34162787-6A06C3BA-BE67-4C01-8A6E-2DB3EBED42B4

Q34162787-93DE465C-936D-4960-B540-69D947580691

Q34162787-B38C9228-5DBB-4AD5-8ECF-BA33000F9414

Q34162787-B9002161-92CE-410E-A0C3-235501877736

Q34162787-EEC404BE-2855-417A-9A38-4A2373144212

Q34162787-F1496142-E5A1-4548-B930-1DB807877FCB

P2860

Q34162787-029F8AE0-D405-4E16-9C9C-5C23FD26DB58

Q34162787-082CC380-80B3-4D2D-A0EA-206490F56FEE

Q34162787-0E2A8080-E0CD-4974-8D5F-F3274402644A

Q34162787-2231A476-FF87-4802-8C27-1339B91E75D6

Q34162787-293A75A0-B66C-4ECD-9D91-E4564A493FB6

Q34162787-29FCCAA7-138A-4F0E-9C50-CBD8C4B39117

Q34162787-2ADD16DF-D54F-4216-B106-A0C75B660E2D

Q34162787-3AA957E1-8EED-4DAB-B50E-29EB88147D4B

Q34162787-3C638B98-6C46-44A1-BDF2-836EFD86E49D

Q34162787-3C68AA23-E374-4317-ADD1-58F70BA927CD

P304

Q34162787-95CD9677-FB3F-467C-ADF3-537FC3067230

P31

Q34162787-692586C6-AAEE-4BBE-8772-57E1ADC27D7B

P356

Q34162787-B68926CC-A401-4508-BB9B-EB42367543F4

P407

Q34162787-5BE9BBC7-BBDB-4F85-861F-FAE258F6687C

P433

Q34162787-470C2CF8-E952-4C8E-9072-D3EF6E2AECD6

P478

Q34162787-B719EBAA-BC70-4236-A0C9-28EB5D04F1E0

P50

Q34162787-F69943BE-089D-47F5-9EDF-113BA0571441

P577

Q34162787-5308E728-FC95-4101-9033-B6FE4CC274EB

P5875

Q34162787-D89C0206-1B20-41A4-80A7-98E21E339D34

P698

Q34162787-085E0556-C013-4251-A29B-5A5854221545

P932

Q34162787-22463C89-115E-4CD5-950E-BF636D7285CA

P356

JOURNAL.PONE.0031323

P1433

P1476

KLC1-ALK: a novel fusion in lu ...... paraffin-embedded tissue only

@en

P2093

Emiko Sugawara

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Mano

http://www.w3.org/2001/XMLSchema#string

Manabu Soda

http://www.w3.org/2001/XMLSchema#string

Reimi Asaka

http://www.w3.org/2001/XMLSchema#string

Satoko Hatano

http://www.w3.org/2001/XMLSchema#string

Seiji Sakata

http://www.w3.org/2001/XMLSchema#string

Takashi Nakajima

http://www.w3.org/2001/XMLSchema#string

Yuki Togashi

http://www.w3.org/2001/XMLSchema#string

P2860

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

Defective kinesin heavy chain behavior in mouse kinesin light chain mutants

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer.

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

Crizotinib in anaplastic large-cell lymphoma.

P304

e31323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0031323

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221844866

http://www.w3.org/2001/XMLSchema#string

P698

22347464

http://www.w3.org/2001/XMLSchema#string

P932

3275577

http://www.w3.org/2001/XMLSchema#string